Pyridinyl imidazoles inhibit the inflammatory phase of delayed type hypersensitivity reactions without affecting T-dependent immune responses
- 31 October 1994
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 16 (10) , 795-804
- https://doi.org/10.1016/0192-0561(94)90053-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Tumour necrosis factor soluble receptors behave as acute phase reactants following surgery in patients with rheumatoid arthritis, chronic osteomyelitis and osteoarthritisClinical and Experimental Immunology, 1993
- Soluble tumor necrosis factor receptors in human inflammatory synovial fluidsArthritis & Rheumatism, 1993
- Effects of pyridinyl imidazole compounds on murine TNF-α productionInflammation Research, 1993
- SK&F 86002 Inhibits Tumor Necrosis Factor Formation and Improves Survival in Endotoxemic RatsJournal of Cardiovascular Pharmacology, 1991
- CYTOKINES: COORDINATORS OF IMMUNE AND INFLAMMATORY RESPONSESAnnual Review of Biochemistry, 1990
- Inhibitory effect of SK&F 86002 on monocyte IL-1 productionInflammation Research, 1989
- Effect of SK&F 86002 on cytokine production by human monocytesInflammation Research, 1989
- Effect of inhibitors of eicosanoid metabolism in murine collagen‐induced arthritisArthritis & Rheumatism, 1988
- Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002International Journal of Immunopharmacology, 1988
- A modified assay for interleukin-1 (IL-1)Journal of Immunological Methods, 1985